Pets At Home Group/£PETS

08:00
10:10
12:15
14:25
16:30
1D1W1MYTD1Y5YMAX

About Pets At Home Group

Pets at Home Group PLC, founded in 1991, operates as a leading pet care brand in the UK. The company specializes in retailing pet food, pet products, accessories, and offering veterinary services across its widespread network of stores and online platforms. Pets at Home operates in a myriad of sectors including retail of pet supplies, veterinary care through its Vet Group, and grooming services, ensuring comprehensive care and products for pets and their owners.

Ticker

£PETS

Primary listing

LSE

Employees

11,597

PETS Metrics

BasicAdvanced
£936M
11.12
£0.19
0.94
£0.13
6.22%

What the Analysts think about PETS

Analyst ratings (Buy, Hold, Sell) for Pets At Home Group stock.

Bulls say / Bears say

The Vet Group recorded 13% revenue growth in FY 2025, creating a solid earnings buffer despite a softer retail sector (Reuters via turn0news13).
Management’s launch of a £25 million share buyback in June 2025 reflects confidence in the business and supports shareholder returns (RTTNews via turn2search3).
Digital sales returned to double-digit growth with the completion of a new distribution centre, showcasing improved e-commerce and operational strength (Proactive Investors via turn0search1).
Retail sales dropped 3% in the 16 weeks to July 17, 2025, signaling ongoing weakness in consumer spending on pet products within the company’s core retail unit (Proactive Investors).
For fiscal 2026, management forecasted underlying pre-tax profit of £115-125 million, down from £133 million in FY 2025, pointing to margin pressure due to higher operating costs and muted consumer demand (Reuters via turn0news13).
The CMA’s provisional move to cap prescription fees at £16 could limit pricing power and squeeze margins in the fast-growing veterinary services business (Reuters via turn1news12).
Data summarised monthly by Lightyear AI. Last updated on 4 Nov 2025.

PETS Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

PETS Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £PETS

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs